Heptares names new CMO
This article was originally published in Scrip
Executive Summary
Heptares Therapeutics, a drug discovery company focused on the development of GPCRs (G protein-coupled receptors), a superfamily of drug receptors linked to a wide range of human diseases, has named Dr Tim Tasker chief medical officer. Prior to joining the Hertfordshire, UK-based firm, Dr Tasker spent 20 years at GlaxoSmithKilne leading Phase I clinical research units, before setting up his own consulting firm.